Literature DB >> 10357052

Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans.

J E Hoppe1, P Frey.   

Abstract

Six commercial tests (Albicans ID, bioMérieux, France; CandiSelect, Sanofi Diagnostics Pasteur, France; CHROMagar Candida, Becton Dickinson, USA; Fluoroplate Candida, Merck, Germany; Fongiscreen 4H, Sanofi Diagnostics Pasteur; and Murex Candida albicans, Murex Diagnostics, USA) and the germ-tube test for presumptive identification of Candida albicans were evaluated using clinical isolates of Candida albicans (n = 350) and of non-albicans yeasts (n = 135). Sensitivities and specificities of all tests regarding the identification of Candida albicans were greater than 97%. The two tests that also allow presumptive identification of some non-albicans yeasts (CHROMagar Candida and Fongiscreen 4H) did not identify all isolates of Candida glabrata and Candida tropicalis. In addition, CHROMagar Candida identified as Candida glabrata some isolates belonging to different species of non-albicans yeasts.

Entities:  

Mesh：

Year:  1999        PMID： 10357052     DOI： 10.1007/s100960050256

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  8 in total

1.  Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis.

Authors:  A Borst; B Theelen; E Reinders; T Boekhout; A C Fluit; P H M Savelkoul
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Discrimination between Candida albicans and other pathogenic species of the genus Candida by their differential sensitivities to toxins of a panel of killer yeasts.

Authors:  P Buzzini; A Martini
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Prospective evaluation of the new chromogenic medium Candida ID, in comparison with Candiselect, for isolation of molds and isolation and presumptive identification of yeast species.

Authors:  Valerie Letscher-Bru; Marie-Helene Meyer; Anne-Cecile Galoisy; Jocelyn Waller; Ermanno Candolfi
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

4.  Use of Mueller-Hinton broth and agar in the germ tube test.

Authors:  Antonella Souza Mattei; Sydney Hartz Alves; Cecília Bittencourt Severo; Luciana da Silva Guazzelli; Flávio de Mattos Oliveira; Luiz Carlos Severo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

5.  Rapid Evaporative Ionisation Mass Spectrometry (REIMS) Provides Accurate Direct from Culture Species Identification within the Genus Candida.

Authors:  Simon J S Cameron; Frances Bolt; Alvaro Perdones-Montero; Tony Rickards; Kate Hardiman; Alireza Abdolrasouli; Adam Burke; Zsolt Bodai; Tamas Karancsi; Daniel Simon; Richard Schaffer; Monica Rebec; Julia Balog; Zoltan Takáts
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

6.  Significance of amplified fragment length polymorphism in identification and epidemiological examination of Candida species colonization in children undergoing allogeneic stem cell transplantation.

Authors:  L M Ball; M A Bes; B Theelen; T Boekhout; R M Egeler; E J Kuijper
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species.

Authors:  Mine Yücesoy; Serhat Marol
Journal:  Ann Clin Microbiol Antimicrob       Date:  2003-10-29       Impact factor: 3.944

8.  Oral Candida spp carriers: its prevalence in patients with type 2 diabetes mellitus.

Authors:  Ramon Felipe Fernandez Martinez; Alejandra Jaimes-Aveldañez; Francisco Hernández-Pérez; Roberto Arenas; Guadalupe Fabián-San Miguel
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.